Skip to main content

Complementary and coordinate markers for detection of epithelial ovarian cancers

  • Chapter
Ovarian Cancer 3

Abstract

Early detection of ovarian cancer might substantially improve results of therapy. After careful surgical staging, 90% of patients with stage I disease and 70% of patients with stage II disease can be cured with currently available therapy. Epithelial ovarian cancer may be one of the malignancies that lends itself to early detection with a blood test. Antigens shed from the ovarian surface into the peritoneal cavity are taken up by diaphragmatic lymphatics and pass through the alternative thoracic duct into the venous circulation. In early work by Knauf and Urbach [1] the OCA antigen could be detected in 70% of patients with early stage disease. OCA was also found in approximately 10% of healthy individuals, precluding its use in screening. This observation did, however, suggest that shed tumor products could be found in the circulation in an early stage of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Knauf, S. and Urbach, G.I. (1980) A study of ovarian cancer patients using a radioimmunoassay for human ovarian tumorassociated antigen OCA. Am. J. Obstet. Gynecol., 138,1222–3.

    PubMed  CAS  Google Scholar 

  2. Bast, R.C. Jr., Klug, T.L., St John, E. et al., (1983) A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N. Engl. J. Med., 309, 883–7.

    Article  PubMed  Google Scholar 

  3. Bast, R.C. Jr., Siegal, P.P., Runowicz, C. et al., (1985) Elevation of serum CA 125 prior to diagnosis of epithelial ovarian carcinoma. Gynecol. Oncol., 22,115–20.

    Article  PubMed  Google Scholar 

  4. Zurawski, V.R. Jr., Orjaseter, H., Andersen, A. and Jellum, E. (1988) Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: relevance for early detection of ovarian cancer. Int. J. Cancer, 42, 677–80.

    Article  PubMed  Google Scholar 

  5. Jacobs, I. and Bast, R.C. Jr. (1989) The CA 125 tumour-associated antigen: a review of the literature. Hum. Reprod., 4,1–12.

    PubMed  CAS  Google Scholar 

  6. Einhorn, N., Sjovall, K., Knapp, R.C. et al, (1992) Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet. Gynecol., 80,14–18.

    PubMed  CAS  Google Scholar 

  7. Ramakrishnan, S., Xu, F.J., Brandt, S.J. et al, (1989) Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines. J. Clin. Invest., 83, 921–6.

    Article  PubMed  CAS  Google Scholar 

  8. Xu, F.J., Ramakrishnan, S., Daly, L. et al, (1991) Increased serum levels of macrophage colony- stimulating factor in ovarian cancer. Am. J. Obstet. Gynecol., 165,1356–62.

    PubMed  CAS  Google Scholar 

  9. Xu, F.J., Yu, Y.H., Li, B.Y. et al, (1991) Development of two new monoclonal antibodies reactive to a surface antigen present on human ovarian epithelial cancer cells. Cancer Res., 51, 4012–19.

    PubMed  CAS  Google Scholar 

  10. Xu, F.J., Yu, Y.A., Daly, L. et al, (1993) The OVXl radioimmunoassay complements CA 125 for predicting the presence of residual ovarian carcinoma at second look surgical surveillance procedures. J. Clin. Oncol., 11, 1506–10.

    PubMed  CAS  Google Scholar 

  11. Woolas, R.P., Xu, F.J., Jacobs, I.J.et al, (1993) Elevation of multiple serum markers in stage I ovarian cancer. J. Natl Cancer Inst., in press.

    Google Scholar 

  12. Jacobs, L, Prys Davies, A. and Oram, D. (1992) Role of CA-125 in screening for ovarian cancer. In Ovarian Cancer 2: Biology, Diagnosis and Management, (eds P. Sharp, W.P. Mason and W. Creasman), Chapman & Hall, London, pp. 265–76.

    Google Scholar 

  13. Woolas, R., Jacobs, I.J., Xu, F.J. et al, (1993) Serum levels of CA 125, M-CSP and OVXl in stage I and preclinical ovarian cancer. Proc. Am. Sac. Clin. Oncol., 12,110.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Chapman & Hall

About this chapter

Cite this chapter

Bast, R.C. et al. (1995). Complementary and coordinate markers for detection of epithelial ovarian cancers. In: Sharp, F., Mason, P., Blackett, T., Berek, J. (eds) Ovarian Cancer 3. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0136-4_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0136-4_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-0138-8

  • Online ISBN: 978-1-4757-0136-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics